4 studies found for:    17622601 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
Conditions: Type 2 Diabetes;   Incretinomimetics;   Pancreas
Interventions: Drug: Incretinomimetics;   Drug: DPP-4 inhibitors
2 Unknown  Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases
Conditions: Type 2 Diabetes Mellitus;   Chronic Liver Disease
Interventions: Drug: UDCA;   Drug: Sitagliptin
3 Recruiting The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
Conditions: Weight Loss;   Obesity
Interventions: Drug: Byetta (exenatide);   Behavioral: Weight loss;   Other: Metabolic Chamber;   Drug: Placebo
4 Completed Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals
Conditions: Diabetes Mellitus Type 1;   Diabetes Mellitus Type 2
Intervention: Drug: Sitagliptin (Januvia)

Indicates status has not been verified in more than two years